David A. Siegel Singular Genomics Systems, Inc. Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.1 - $2.95 $12,320 - $33,040	-11,200 Reduced 32.65%	23,100 $27,000
Q4 2022 Feb 14, 2023	SELL	$1.82 - $2.71 $19,474 - $28,997	-10,700 Reduced 23.78%	34,300 $68,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $80,750 - $152,779	-32,300 Reduced 41.79%	45,000 $113,000
Q2 2022 Aug 15, 2022	BUY	$2.86 - $6.44 $221,078 - $497,812	77,300 New	77,300 $295,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $948M
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.